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Abstract
Background: Mouse genetic study has demonstrated that Axin2 is essential for calvarial development and disease.
Haploid deficiency of b-catenin alleviates the calvarial phenotype caused by Axin2 deficiency. This loss-of-function
study provides evidence for the requirement of b-catenin in exerting the downstream effects of Axin2.
Results: Here we utilize a gain-of-function analysis to further assess the role of b-catenin. A transgenic expression
system permitting conditional activation of b-catenin in a spatiotemporal specific manner has been developed.
Aberrant stimulation of b-catenin leads to increases in expansion of skeletogenic precursors and the enhancement
of bone ossification reminiscent to the loss of Axin2. The constitutively active signal promotes specification of
osteoprogenitors, but prevents their maturation into terminally differentiated osteoblasts, along the osteoblast
lineage. However, the prevention does not interfere with bone synthesis, suggesting that mineralization occurs
without the presence of mature osteoblasts. b-catenin signaling apparently plays a key role in suture development
through modulation of calvarial morphogenetic signaling pathways. Furthermore, genetic inactivation of the
b-catenin transcriptional target, cyclin D1, impairs expansion of the skeletogenic precursors contributing to
deficiencies in calvarial ossification. There is a specific requirement for cyclin D1 in populating osteoprogenitor cell
types at various developmental stages.
Conclusion: These findings advance our knowledge base of Wnt signaling in calvarial morphogenesis, suggesting
a key regulatory pathway of Axin2/b-catenin/cyclin D1 in development of the suture mesenchyme.
Background
The mammalian skull consists of neurocranium and vis-
cerocranium that are formed from skeletogenic
mesenchyme derived from both mesoderm and neural
crest [1]. The cranial skeletogenic mesenchyme mainly
undergoes intramembranous ossification to form the
bone plates [2]. This process differs from endochondral
ossification in the appendicular and axial skeletons,
which prior formation of cartilage templates is required.
The growth of calvaria is then able to accommodate
expansion of the brain [2]. During calvarial morphogen-
esis, cranial sutures serve as skeletogenic growth centers
where undifferentiated stem cells develop into calvarial
osteoprogenitors, which differentiate to become pre-
osteoblasts/osteoblasts localized to the osteogenic front
and periosteum. The mature cells then deposit and
mineralize bone matrix. Osteoblasts either die by apop-
tosis or are embedded in the matrix, becoming
osteocytes.
A patent suture is necessary for continuous growth
of the skull bones. Defects in either cell proliferation,
differentiation, or apoptosis affecting the process of
intramembranous ossification have been shown to
induce premature fusion of cranial sutures, leading to
development of craniosynostosis [3]. Abnormalities in
the developing suture cause severe malformations of the
skull, leading to disruption of brain development. Cra-
nial dysmorphism resulting from suture closure defects
can be familial or sporadic in origin [3-5]. Although
linkage analyses have shown that genetic mutations are
associated with synostosis-related syndromes, the
mechanism underlying suture development remains
largely elusive. It remains a challenge to understand the
maintenance of suture patency which may require undif-
ferentiated cells to be present. These naïve cells are
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any medium, provided the original work is properly cited.thought to be localized in the suture mesenchyme. Better
understanding of the genetic regulatory network convey-
ing signals to orchestrate the suture morphogenetic pro-
cesses promises important insights into pathogenesis of
congenital deformities.
Our previous work has linked an evolutionary con-
served Wnt signal transduction pathway for the first
time to craniosynostosis [6]. Mice with genetic inactiva-
tion of Axin2, a negative regulator targeting b-catenin
degradation, exhibit suture abnormalities. The synostosis
phenotype is caused by accelerated intramembranous
ossification mediated through a dual role of b-catenin in
both the expansion of osteoprogenitors and the matura-
tion of osteoblasts [6,7]. Moreover, haploid deficiency of
b-catenin alleviates the premature closure and calvarial
osteoblast defects. The loss-of-function analysis thus
suggests the requirement of b-catenin in Axin2
mediated calvarial morphogenesis.
In this study, we employ a gain-of-function analysis to
determine if aberrant activation of b-catenin induces
calvarial defects reminiscent to the Axin2 mutant. A
transgenic system integrating the tetracycline-dependent
activation and Cre-mediated recombination methods has
been developed. Our findings demonstrate that induci-
ble stimulation of b-catenin causes severe suture
abnormalities resembling those with the Axin2 ablation.
The expansion of skeletogenic precursors and their sub-
sequent differentiation are altered, leading to increased
bone ossification. b-catenin signaling plays a critical role
in development of the suture mesenchyme through
modulation of calvarial morphogenetic signaling path-
ways. Furthermore, analyzing mice with disruption of
the b-catenin transcriptional target, cyclin D1, we reveal
its essential role in the expansion of skeletal precursors.
Cyclin D1 is required for propagation of specific types
of osteoprogenitors at various developmental stages.
Results
We previously showed that Axin2 is expressed in the
suture mesenchyme, osteogenic fronts and periosteum
essential for suture morphogenesis [6]. To investigate if
stimulation of b-catenin leads to a causal effect on
osteoblast proliferation and differentiation similar to the
Axin2 mutant phenotype, a transgenic system permit-
ting manipulation of gene activity in the Axin2-expres-
sing cells was created. Using the Axin2-rtTA transgenic
mouse strain expressing an improved version of rtTA,
rtTA2
S-M2, under control of the Axin2 promoter, we
tested the capability of conditional gene expression in
the developing calvaria. Mice carrying the Axin2-rtTA
transgene were crossed with TRE-lacZ mice to obtain
double transgenic mice (Figure 1A). Their mother was
treated with doxycycline (Dox) to induce expression of
t h el a c Zr e p o r t e ri nt h e4d a y - o l dp u p s .T h ed o u b l e
Figure 1 Inducible activation of b-catenin causes deficiencies
in calvarial morphogenesis. (A) A schematic represents the
strategy for targeted expression in the Axin2-expressing cells. Four
day-old mice carrying Axin2-rtTA and TRE-lacZ transgenes without
(B) or with (C) the Dox treatment, starting at E16.5, were analyzed
for expression of the reporter. b-gal staining reveals strong
expression of lacZ in the developing skull. Sections of the b-gal
stained skulls at three different levels (D, internasal suture; E,
metopic suture; F, sagittal suture) indicated in C exhibit targeted
gene expression in the suture mesenchyme, osteogenic fronts
(arrowheads), and periosteum (asterisks). (G) A scheme represents
the development of a transgenic system, which integrates the
tetracycline-dependent activation and Cre-mediated recombination,
to express a degradation-deficient form of b-catenin (sb-cat) in the
Axin2-expressing cells. (H-J) Skeletal staining of control (H, genotype:
Axin2-rtTA; b-cateninΔEx3Fx/+) and sbcat
Ax2 (I, J) mice reveals skull
abnormalities caused by the expression of sb-cat around P17. (K-P)
H&E staining shows that conditional expression of sb-cat expands
metopic suture mesenchyme (K-M) and enhances bone ossification
(N-P). The suture regions are enlarged in the sbcat
Ax2 mutants (L, M)
compared to the control (K). Frontal bone volumes are increased in
the sbcat
Ax2 skulls (O, P) compared to the control (N). Arrowheads
indicate the osteogenic fronts. F, frontal bone; P, parietal bone.
Scale bars, 2 mm (B, C, H-J); 200 μm (D-F, K-M); 100 μm (N-P).
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signal was detected in the control (Figure 1B, C). Com-
pared with the endogenous Axin2 expression pattern
that is detected by b-gal staining using the Axin2
lacZ
knock-in mouse strain [6], the results showed that
expression of the lacZ reporter was successfully targeted
to the suture mesenchyme, osteogenic fronts and perios-
teum of developing sutures (Figure 1D-F). Similar
results could also be obtained using a different reporter,
TRE-H2BGFP, suggesting that the Axin2-rtTA trans-
genic strain permits inducib l eg e n ee x p r e s s i o nd u r i n g
calvarial morphogenesis [8].
We then developed a transgenic system combining the
tetracycline-dependent activation and Cre-mediated
recombination methods to determine if aberrant activa-
tion of b-catenin affects suture development (Figure 1G).
This advanced system permits inducible stimulation of
b-catenin during calvarial morphogenesis. It allows us to
test if constitutive activation of b-catenin signaling causes
suture abnormalities, leading to defects in skeletogenesis,
similar to that observed in the Axin2 nulls. First, mice
carrying the Axin2-rtTA transgene were crossed with the
TRE-Cre mice to obtain the Axin2
Cre model. Next, the
b-catΔEx3Fx allele was introduced to the Axin2
Cre mice.
In these triple transgenic animals, Cre recombinase was
produced in the Axin2-expressing cells in the presence of
Dox. The expressed Cre then deleted exon 3 of b-catenin
to generate a truncated protein. As a result, a stabilized
dominant protein (sb-cat), which lacks important phos-
phorylation sites [9] and cannot be targeted for proteo-
some degradation, was generated in the Axin2-expressing
cells (Figure 1G). This sbcat
Ax2 mouse model permits sti-
mulation of b-catenin in a spatiotemporal specific fashion
during formation of the craniofacial skeleton. Inducible
expression of sb-cat in the Axin2-expressing cells had
significant effects on craniofacial skeletogenesis (Figure
1H-J). The suture regions of the sbcat
Ax2 mice were dras-
tically expanded (Figure 1K-M). In addition, bone ossifi-
cation was enhanced in these mutants compared to the
control (Figure 1N-P).
Further investigations revealed an increased number
of Ki67 positive cells in the sbcat
Ax2 suture region
(Figure 2A, B, G; p value = 0.0024, n = 4). Similar to that
observed in the Axin2 nulls, the expression of a direct
Wnt target, cyclin D1, was highly stimulated (Figure 2C,
D, G; p value = 0.0026, n = 3). This was accompanied by
stabilization of its target Cdk4, which promotes cell cycle
G1/S transition (Figure 2E, F, G; p value = 0.0425, n = 3).
Statistical analysis showed that these alterations in cell
proliferation significantly contribute to the mesenchymal
defects of the sbcat
Ax2 sutures (Figure 2G). Constitutive
stimulation of b-catenin causes a detrimental effect on
the expansion of skeletal precursors in the developing
suture.
We next determined if osteoblast lineage development
is affected in the sbcat
Ax2 mutants. Osteogenic markers
expressed at different stages along the osteoblast differ-
entiation pathway were examined (Figure 3). At the
osteogenic fronts, we detected that the area of Runx2-
expressing cells is expanded in the mutants (Figure 3A, B).
This is also accompanied by expansion of the regions con-
taining Osterix and Col1 positive cells (Figure 3C-F). In
contrast, cells expressing high levels of Osteopontin, a late
marker for mature osteoblasts, were missing at the sbca-
t
Ax2 osteogenic fronts with only very low levels of Osteo-
pontin detected compared to the control counterparts
(Figure 3G, H). This suggests that terminal differentiation
of mature osteoblasts expressing high levels of Osteopon-
tin is prohibited. Nonetheless, there is no question that
bone ossification is aberrantly elevated in the mutant
skulls (Figure 1). To test if inducible expression of sb-cat
promotes differentiation of calvarial precursors into
osteoblasts, we then used an ex vivo culture system. In
the control culture, which lacks the TRE-Cre transgene
Figure 2 Stimulation of b-catenin interferes with cell
proliferation in the developing suture mesenchyme. (A, B)
Expression of sb-cat increases the number of Ki67 positive cells
suggesting that proliferation of skeletal precursors is enhanced in the
metopic suture at one week after birth. The numbers of cyclin D1
(CycD1; C, D) and Cdk4 (E, F) positive cells also increase drastically in
the mutants. The broken lines define the suture region. (G) Graph
indicates the average percentage of the positive stained cells in the
controls and mutants (mean + SEM). Scale bars, 50 μm (A-F).
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osteoblast differentiation was observed in the presence
of Dox (Figure 3I). However, the Dox-mediated expres-
sion of sb-cat caused a ~3 fold induction of alkaline
phosphatase activity, suggesting that the differentiation
process was stimulated (Figure 3I).
The loss of Axin2 elevates the signaling activities of
FGF and BMP pathways critical for calvarial develop-
ment and disease [6,7]. Therefore, we examined whether
these calvarial morphogenetic pathways are interfered by
the expression of the dominant b-catenin protein in a
manner similar to the Axin2 mutants. Immunostaining
analysis with antibodies recognizing the activated/non
phosphorylated form of b-catenin [10] confirmed its
elevated levels in the sbcat
Ax2 suture (Figure 4A, B).
Fgfr1, Fgfr2 and Fgf2, expressed in the suture mesench-
yme are important regulators for bone ossification and
maintenance of suture patency. Deregulation of these
molecules has been extensively linked to development of
synostosis-related syndromes [3-5,11,12]. FGF signaling,
including Fgfr1 (Figure 4C, D, K; p value = 0.015, n = 3),
Fgfr2 (Figure 4E, F, K; p value = 0.0173, n = 3) and Fgf2
(Figure 4G, H, K; p value = 0.0092, n = 3), affected by
Figure 3 Development of the osteoblast lineage is affected in
the sbcat
Ax2 mice. Immunostaining analysis examines the
expression of osteogenic markers, Runx2 (A, B), Osterix (C, D), Col1
(E, F) and Osteopontin (G, H), in the one week old control (A, C, E,
G) and sbcat
Ax2 (B, D, F, H) mice. Brackets indicate the expression
domains. (I) The expression of sb-cat accelerates osteoblast
differentiation in vitro. The control (Axin2rtTA; b-cateninΔEx3Fx/+)
and mutant (Axin2rtTA+; TRE-Cre+; b-cateninΔEx3Fx/+) calvarial cells,
isolated from the newborn skulls, were induced for differentiation
for 6 days. Alkaline phosphatase liquid assay shows that the
presence of Dox has minimal effect on osteoblast differentiation in
the controls. However, the inducible expression of sb-cat results in
accelerated differentiation. The diagram is a representative of two
independent experiments. Scale bars, 50 μm (A-H).
Figure 4 FGF and BMP signaling is stimulated by sb-cat in the
developing suture. Immunostaining analysis reveals that b-catenin
gain-of-function mutation alters the population of the b-catenin (A, B),
Fgfr1 (C, D), Fgfr2 (E, F), Fgf2 (G, H) and phosphorylated Smad1/5/8
(I, J) expressing cells in the metopic suture at one week after birth. The
broken lines define the suture region. (K) Graph shows the average
percentage of positive stained cells in the controls and mutants (mean
+ SEM). Scale bars, 50 μm (A-J).
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Ax2
mutants. Stimulated expression of phosphorylated
Smad1/5/8 proteins found in the Axin2 nulls was also
observed by the expression of sb-cat (Figure 4I, J, K;
p value = 0.0033, n = 3). The results imply that b-catenin
stimulation is able to recapitulate the effect of the Axin2
ablation, leading to activation of the FGF and BMP path-
ways (Figure 4K).
Our findings demonstrated that stimulation of b-cate-
nin in the skeletogenic mesenchyme promotes expan-
sion of skeletal precursors, specification of osteoblast
cell types, maturation of matrix-producing osteoblasts,
and FGF and BMP signaling. These phenotypic and reg-
ulatory defects, reminiscent to the Axin2 deficiency,
thus provide evidence to support an essential role of
b-catenin in mediating the Axin2-null phenotypes using
a gain of function approach.
Disruption of Axin2/b-catenin signaling consistently
alters the regulation of its downstream transcription tar-
get, cyclin D1, in the canonical Wnt pathway [6,7]. The
number of cyclin D1 positive cells also increases from 7%
in the control to 78% in the sbcat
Ax2 suture region
(Figure 2G). However, there is a lack of knowledge on
the essential role of cyclin D1 in calvarial morphogenesis,
contributing to the defects caused by aberrant Axin2/
b-catenin signaling. To definitively assess the requirement
of cyclin D1 in development of the craniofacial skeleton,
we examined the skull defects caused by its disruption in
mice. The loss of cyclin D1 apparently interfered with
bone mineralization causing a delay of ossification at the
newborn stage (Figure 5A, B). A large foramen was
observed in the cyclin D1-null skulls, especially in the
frontal bones (Figure 5C, D). Von Kossa staining showed
decreased mineralization, resulting in a wider suture
region, caused by the mutation (Figure 5E, F). Cyclin D1 is
therefore essential for suture morphogenesis.
To elucidate the mechanism underlying the calvarial
abnormalities of cyclin D1-/- mice, we examined devel-
opment of the osteoblast lineage during embryogenesis.
At E15.5, the cyclin D1 deletion reduced the calvarial
regions, expressing Runx2 (Figure 6A, B), Osterix
(Figure 6C, D) and Osteopontin (Figure 6E, F). Similar
defects were also observed at E17.5 (see below and data
not shown). In the E15.5 mutants, bone mineralization
was not yet detected by von Kossa staining analysis
(Figure 6G, H), suggesting an impairment of osteoblast
development caused by the loss of cyclin D1.
The impaired osteoblast development might be attribu-
ted to defects in expansion of the skeletal precursors in
cyclin D1-/- mutants. We therefore examined the well
established role of cyclin D1 in cell proliferation affected
by the mutation. First, in vitro proliferation analysis of ske-
letal precursors isolated from the wild type and mutant
calvaria indicated that the cyclin D1 deletion has a
negative effect on cell proliferation (Figure 7A). We next
examined the skeletal precursors undergoing mitotic
divisions which are positive for Ki67 and Runx2 in the
metopic sutures (Figure 7B-D). Co-localization analysis
revealed two populations of skeletogenic precursors in the
suture mesenchyme (Figure 7E). While the proliferating
cells did not express Runx2 at the midline suture region
(Figure 7F), they are Runx2 positive at the osteogenic
fronts (Figure 7G). The results thus suggest that there are
two distinct populations of naïve cells actively proliferating
in the developing suture mesenchyme.
Further examination revealed that cyclin D1 deficiency
reduced both Runx2 negative and positive populations
at E17.5 (Figure 7H, I, L, M). However, at newborn, the
expression of Ki67 (Figure 7J, N) remained affected at
the suture mesenchyme, but became unaffected at the
osteogenic fronts of cyclin D1-/- which are Runx2-
expressing cells (Figure 7K, O). This implies that the
cyclin D1 ablation interferes with the expansion of naïve
cells in the developing suture at early developmental
stages. As the development proceeds, the effects on the
committed osteoprogenitors were somehow alleviated.
At newborn, we also observed the status of FGF and
BMP signaling in the skeletal precursors at the osteo-
genic fronts of cyclin D1-/-, which were comparable to
the wild type counterparts (Additional file 1 Figure S1).
The skeletogenic activities at the mutant osteogenic
fronts appeared to be restored at newborn.
Figure 5 Cyclin D1 is essential for skull and suture
development. (A-D) Skeletal staining of P0 mice reveals calvarial
ossification defects associated with inactivation of cyclin D1 (CycD1
+/+; A, C and CycD1-/-; B, D). Enlargements of insets in A and B are
shown in panels C and D. (E, F) The loss of cyclin D1 affects
ossification of the bone plate analyzed by von Kossa staining.
Arrows indicate the osteogenic fronts of CycD1+/+ (E) and CycD1-/-
(F). Scale bars, 2 mm (A, B); 1 mm (C, D); 100 μm (E, F).
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Runx2 (A, B), Osterix (OSX, C, D) and Osteopontin (OP, E, F) in cyclin D1+/+ (A, C, E) and cyclin D1-/- (B, D, F) mice. Von Kossa staining reveals
that the deletion of cyclin D1 results in the absence of bone mineralization at the calvaria (Figure 6G, H). The broken lines indicate the positively
stained domains. Scale bar, 0.5 mm (A-H).
Figure 7 Expansion of skeletogenic precursors is impaired by the cyclin D1 mutation. (A) Cyclin D1 mutation reduces skeletal precursor
proliferation in vitro. Primary calvarial cells, isolated from the CycD1+/+ and CycD1-/- newborns, are analyzed by BrdU incorporation and Ki67
staining assays. The immunostained images are taken randomly to determine the percentage of positive cells (n = 3). (B-G) Double labeling
reveals the proliferating skeletogenic precursor populations that are Runx2 negative and positive in the metopic suture. Co-immunostaining of
Ki67 (B) and Runx 2 (C), and counterstaining with DAPI (D), show cells undergoing mitotic divisions with (arrow) or without (arrowhead) the
expression of Runx2 (E) at E17.5. Enlargements of the insets (E) are shown in F and G. (H-O) Impaired skeletogenic activity at the osteogenic
fronts of CycD1-/- during embryogenesis is restored at birth. Immunostaining of the E17.5 (H, I, L, M), or newborn (J, K, N, O), CycD1+/+ (H-K)
and CycD1-/- (L-O) metopic sutures with Ki67 (H, J, L, N) and Runx2 (I, K, M, O) identify cells undergoing mitotic divisions and expressing Runx2,
respectively. At E17.5, the deletion of cyclin D1 affects the presence of Ki67 (H, L) and Runx2 (I, M) positive cells at both suture mesenchyme
(Runx2-, arrowhead) and osteogenic fronts (Runx2+, arrows). At newborn, the expression of Ki67 (J, N) remains affected at the midline suture
(arrowhead), but becomes unaffected at the osteogenic fronts (arrows) of CycD1-/- which also contain Runx2-expressing cells (K, O). The suture
areas and osteogenic fronts are highlighted by broken lines. Scale bars, 200 μm (B-E); 100 μm (H, L); 50 μm (F, G, I-K, M-O).
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seems to be the cause of ossification delay which results
i naw i d eo p e ns u t u r eb e t w e e nt h eb o n ep l a t e sa tb i r t h .
Both the Runx2 negative and positive skeletogenic pre-
cursors are affected during embryogenesis. However, the
cyclin D1 deletion disrupts only proliferation of the
naïve cells which do not express Runx2 while the Runx2
positive cells at the osteogenic fronts maintain active
proliferation at newborn. One possibility is that the loss
of cyclin D1 is compensated by other D-type cyclins
[13]. Alternatively, other cyclins with similar function, e.
g. E-type, have been reported to be elevated due to the
loss of cyclin D1 [14]. Analysis of mice expressing only
a single D-type cyclin each has revealed that the tissue
specific expression patterns of the other remaining
cyclin D proteins are lost [15]. To test these possibilities,
we therefore examined the expression of other G1/S
cyclins. The expression of cyclin D2, D3 and E were
detected at the osteogenic fronts at newborn (Figure 8A,
C, E). Their strong presences were also found in the
cyclin D1 mutants (Figure 8B, D, F). The results suggest
that compensations by these cyclins with similar func-
tion to cyclin D1 could occur at the osteogenic fronts to
overcome the mutation. Thus provides a mechanism
underlying the independence of cyclin D1 on postnatal
development of the calvaria.
Discussion
Studies in the past have suggested the importance of
b-catenin signaling in modulating osteoblast prolifera-
tion and differentiation in health and disease [16-23]. It
has been previously proposed that proliferation of skele-
tal precursors requires b-catenin [16,18]. In the subse-
quent development of osteoblasts, b-catenin needs to be
activated [16-18]. Our prior study of mice with disrup-
tion of Axin2 also indicates a dual role of b-catenin in
expansion of skeletal precursors and their differentiation
into osteoblasts [6]. There is no question about the
essential function of b-catenin in regulating the expan-
sion of skeletal precursors. However, there is a need to
obtain additional in vivo evidence for its involvement in
the maturation process. This has been an obstacle due
to the effect of cell proliferation also interfering with
cell differentiation. Indeed, both deletion and stimula-
tion of b-catenin in the skeletogenic mesenchyme result
in delay of calvarial development at embryonic stages
[16,17].
Using sophisticated mouse genetic systems, we are
able to further our investigation by manipulating the
activity of b-catenin in the Axin2-expressing cells within
the suture mesenchyme. This study provides direct in
vivo evidence to support that b-catenin regulates both
proliferation and differentiation of osteogenic precur-
sors. Stimulation of b-catenin with transgenic expression
of a dominant mutant protein in the suture mesench-
yme results in calvarial deformities. In these mutants,
the expansion of skeletal precursors and their differen-
tiation into osteoblasts are highly stimulated. These
abnormalities are reminiscent to those observed in the
Axin2 mutants. The gain-of-function study strongly sup-
ports the hypothesis for a dual role of b-catenin in cell
proliferation and differentiation during osteoblast devel-
opment [6,7].
Increasing lines of evidence [6-8] implicate that cano-
nical Wnt signaling is required for self renewal of
mesenchymal stem cells and the expansion of skeleto-
genic precursors during calvarial morphogenesis. This
notion is manifest on the sbcat
Ax2 model (Figure 9).
Furthermore, the current study is in agreement with
previous suggestion for a continuing role of b-catenin in
specification of osteoprogenitors which are Runx2+ and
Osterix+ osteoblasts [16,24]. There has been a report
indicating that expression of the sbcat
Ax2 mutant pre-
vents terminal differentiation of osteoblasts expressing
high levels of Osteocalcin [18]. We obtained similar
results showing that stimulated b-catenin signaling inhi-
bits the mature osteoblasts to express high levels of
Osteopontin (Figure 9). Nonetheless, this inhibitory
effect does not impair bone mineralization to take place.
Because enhanced ossification is clearly demonstrated in
the sbcat
Ax2 skulls, our results support the previous
observation that b-catenin is essential for maturation of
osteoblast progenitors into bone matrix-secreting osteo-
blasts [18]. Therefore, osteoblasts expressing low levels
of Osteopontin and Osteocalcin are still capable of bone
Figure 8 Presence of other G1/S cyclins at the osteogenic
fronts of cyclin D1-/-. Immunostaining analysis reveals the
expression of cyclin D2 (A, B), D3 (C, D) and E (E, F) at the
osteogenic fronts of wild type (A, C, E) and cyclin D1-null (B, D, F)
metopic suture at newborn. Arrows indicate the osteogenic fronts.
Scale bar, 50 μm (A-F).
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Page 8 of 11synthesis (Figure 9). Genetic studies also indicate that
the deletion of Osteocalcin [25] or Osteopontin [26] in
mice does not impair skeletal development.
The sbcat
Ax2 mice do not seem to display the exact
same phenotype as the Axin2 mutants. Axin2, working
upstream of b-catenin in the canonical Wnt pathway,
might possess additional functions affecting other signal-
ing molecules not regulated by b-catenin. Alternatively,
the presence of Axin1 might compensate for the loss of
Axin2 in a certain degree as these two genes can func-
tionally substitute for each other [27]. While Axin1 is
still able to regulate b-catenin in the Axin2 mutants, the
stabilized form of b-catenin can no longer be modulated
by Axin proteins in the sbcat
Ax2 mice resulting in the
phenotypic difference between the two models.
Because of our model permitting conditional stimula-
tion of b-catenin, we have been able to overcome the
embryonic lethality and examine its role in postnatal
development of the craniofacial skeleton. In early juve-
niles, the calvarium grows rapidly while skeletal precur-
sors are required to expand significantly. Alterations of
b-catenin at this stage cause severe proliferation and dif-
ferentiation defects. In contrast, the skeletal precursor
pool is relatively quiescent after mice are 3 weeks old.
In late juveniles, expansion of skeletal precursors does
not seem to be affected by aberrant b-catenin signaling
while high levels of bone ossification are detected
(Mirando and Hsu, unpublished). Unfortunately, mice
with inducible expression of the dominant b-catenin
protein are unable to survive beyond 4 weeks after the
initial activation of transgene takes place. The lethality
issue, most likely due to the Axin2 promoter being
active in other tissues and organs, has prevented us
from assessing the long term effect of the transgenic
expression. Nonetheless, the new finding nicely comple-
ments our previous work using a loss-of-function analy-
sis in which haploid deficiency of b-catenin alleviates
the skull defects caused by the Axin2 disruption [7].
We have previously shown that as a transcriptional
target of Wnt, cyclin D1 is modulated by alterations of
the Axin2/b-catenin regulatory pathway [6,7]. However,
there is a lack of information on linking the cyclin D1
function to skeletogenesis [28,29]. To assess the role of
cyclin D1 in calvarial morphogenesis, a genetic study
was performed. Cyclin D1 apparently has an essential
function in calvarial development at embryonic stages.
In the cyclin D1 knockout embryos, the expansion of
both Runx2 negative and positive skeletal precursor
populations are impaired at the suture mesenchyme and
osteogenic fronts, respectively. Deficiencies in cell prolif-
eration and differentiation have been shown to cause
ossification delay of the skull [30,31]. We have identified
similar types of ossification deficiencies in the cyclin D1
knockouts. The finding thus provides first genetic evi-
dence for the involvement of cyclin D1 in calvarial mor-
phogenesis (Figure 9).
As a direct transcriptional target of b-catenin, cyclin
D1 acts in this regulatory pathway. However, the loss of
cyclin D1 interferes with only the Runx2 negative naïve
cells within the suture mesenchyme, but not the Runx2
positive progenitors at the osteogenic fronts at new-
borns. The skeletogenic signaling pathways of FGF and
BMP are also unaffected at the osteogenic fronts. Our
data imply that the restoration of skeletogenic activities
at the osteogenic fronts of cyclin D1-/- might be a com-
pensation effect of other cyclins with similar function.
The loss of cyclin D1 may be compensated by cyclin
D2, D3 and E. Nevertheless, we cannot rule out the pos-
sibility that the lethality associated with the cyclin D1
deletion could result in selected phenotypic representa-
tion. This is because only 72% of mice with disruption
of cyclin D1 able to survive after birth [28]. The
mutants with most severe phenotypes are unable to be
obtained due to abnormalities in other tissues and
organs. Furthermore, our study of cyclin D1 in craniofa-
cial skeletogenesis raises a question on its involvement
in development of the axial and appendicular skeletons.
It remains to be determined whether the D-type cyclin
(s) has a role in other developments and maintenance of
the body skeleton.
Conclusions
Using sophisticated mouse genetic studies, we demon-
strate that aberrant stimulation of b-catenin causes
Figure 9 Model for osteoblast lineage development mediated
by the Axin2/b-catenin/cyclin D1 regulatory pathway. Growing
evidence suggests that Axin2/b-catenin regulates the self renewal of
mesenchymal stem cells (MSCs) and the expansion of skeletogenic
progenitors during calvarial morphogenesis [6-8]. This study shows
that cyclin D1 is a downstream modulator, acting in this regulatory
axis. Furthermore, canonical Wnt signaling promotes specification of
osteoprogenitors which are Runx2+ and Osx+, but prohibits
terminal differentiation of mature osteoblasts expressing high levels
of Op. Nonetheless, osteoblasts expressing low levels of Op are
matrix-secreting cells capable of mediating bone synthesis.
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tion. Constitutive activation of b-catenin enhances both
expansion of skeletogenic precursors and bone ossifica-
tion. Together with our previous findings, these results
indicate that b-catenin plays an essential role in the cal-
varial morphogenetic signaling pathways. In addition, as
a direct transcriptional target of b-catenin, cyclin D1 is
required for the expansion of skeletal precursors during
calvarial morphogenesis. This study provides genetic evi-
dence to further support the importance of Wnt signal-
ing in calvarial morphogenesis, suggesting a key
regulatory pathway of Axin2/b-catenin/cyclin D1 in
development of the suture mesenchyme.
Methods
Mouse strains
The Axin2-rtTA [32,33], TRE-lacZ [34,35], TRE-
H2BGFP [8,33,34], TRE-Cre [8], b-catΔEx3Fx [9], cyclin
D1 [28] mouse strains and genotyping methods were
reported previously. To test the Dox-inducible expression
system, mice carrying the Axin2-rtTA and TRE-lacZ
transgenes were obtained and treated with Dox (2 mg/ml
plus 50 mg/ml sucrose) for several days as described
[8,32,34,35]. For generating the sbcat
Ax2 mouse strain,
mice carrying Axin2-rtTA and TRE-Cre transgenes were
first bred into the b-catΔEx3Fx heterozygous background
[8]. The expression of a degradation-deficient b-catenin
in the Axin2-expressing cells was then induced by Dox
treatment at E16.5 or E17.5. Care and use of experimen-
tal animals described in this work comply with guidelines
and policies of the University Committee on Animal
Resources at the University of Rochester.
Cells
Isolation and culture of primary skeletal precursors were
performed as described [6]. Briefly, calvarial cells iso-
lated from newborns were cultured in aMEM media
containing 10% fetal calf serum. Only the first passage
cells were used for the study. To induce the expression
of the transgene, Dox was added to the culture media
for 8 hours. Cells (1 × 10
4) were seeded in 24 well
plates, and maintained in differentiation media contain-
ing 50 μg/ml ascorbic acid and 4 mM b-glyceropho-
sphate for 6 days, followed by alkaline phosphatase
staining as described [6].
Histology, skeletal preparation, b-gal staining and GFP
analysis
Skulls were fixed for skeletal preparation or paraffin
embedded, sectioned and stained with hematoxylin/
eosin for histology or von Kossa staining as described
[6,7]. Details for b-gal staining in whole mounts or
sections were reported previously [32,34,35]. For analysis
in sections, newborn skulls were further fixed in 4%
PFA/PBS, processed for frozen section, and evaluated by
histology using Zeiss Axio Observer microscope (Carl
Zeiss, Thornwood, NY).
Immunostaining analysis
Immunological staining with avidin:biotinlylated enzyme
complex was performed as described [6,7]. The staining
was visualized by enzymatic color reaction or fluores-
cence according to the manufacture’s specification (Vec-
tor Laboratories, Burlingame, CA). Images were taken
using Zeiss Axio Observer microscope. Mouse monoclo-
nal antibodies Cdk4 (Cell Signaling, Danvers, MA), BrdU
(Thermo Fisher, Fremont, CA), Runx2 (MBL Interna-
tional, Woburn, MA), Osteopontin (Developmental Stu-
dies Hybridoma Bank, Iowa City, IA), cyclin D2 (Thermo
Fisher), cyclin D3 (Thermo Fisher), cyclin E (Santa Cruz)
and ABC (recognizing activated/non phosphorylated
form of b-catenin, Upstate; Billerica, MA); rabbit polyclo-
nal antibodies cyclin D1 (Thermo Fisher), Fgfr1 (Santa
Cruz, Santa Cruz, CA), Fgfr2 (Santa Cruz), Fgf2 (Santa
Cruz), Ki67 (Thermo Fisher), Osterix (Abcam, Cam-
bridge, MA) and phospho-Smad1/5/8 (Cell Signaling)
were used in these analyses. For statistical evaluation, the
stained images were taken to determine the percentage
of positive cells by counting the positively stained cells in
a total population of cells (positive plus negative). The
counting process was repeated in different samples for a
number of times (n represents the number of animals or
cell cultures) to obtain the mean values and error bars.
The p values were obtained using student t test.
Additional material
Additional file 1: Figure S1: The skeletogenic activities are restored
at the osteogenic fronts of cyclin D1-/- after birth. Immunostaining
analysis reveals that the expression of Fgf2 (A, B), Fgfr1 (C, D), Fgfr2 (E, F)
and phosphorylated Smad1/5/8 (G, H) is not affected in the mutant
metopic sutures (B, D, F, H) compared to the control (A, C, E, G) at
newborn. Arrows indicate the osteogenic fronts. Scale bars, 50 μm (A-H).
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